Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment
Authors
Keywords
-
Journal
NANO LETTERS
Volume -, Issue -, Pages -
Publisher
American Chemical Society (ACS)
Online
2021-03-02
DOI
10.1021/acs.nanolett.1c00168
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles
- (2020) Suping Li et al. Nature Biomedical Engineering
- Biomimetic Metal-Organic Framework Nanoparticles for Cooperatively Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy
- (2019) Huan Min et al. ADVANCED MATERIALS
- Engineering Biomimetic Platesomes for pH‐Responsive Drug Delivery and Enhanced Antitumor Activity
- (2019) Guangna Liu et al. ADVANCED MATERIALS
- Smart Nanotherapeutic Targeting of Tumor Vasculature
- (2019) Zifu Li et al. ACCOUNTS OF CHEMICAL RESEARCH
- Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug
- (2019) Jian Jiang et al. ADVANCED MATERIALS
- Platelet-Mimicking Biotaxis Targeting Vasculature-Disrupted Tumors for Cascade Amplification of Hypoxia-Sensitive Therapy
- (2019) Mingkang Zhang et al. ACS Nano
- Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment
- (2019) Yinlong Zhang et al. MEDICINAL RESEARCH REVIEWS
- Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment
- (2019) Na Shen et al. NANO LETTERS
- Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers
- (2018) Lesley J. Scott DRUGS
- A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
- (2018) Suping Li et al. NATURE BIOTECHNOLOGY
- Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy
- (2018) Quanyin Hu et al. Nature Biomedical Engineering
- Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours
- (2017) Suping Li et al. Nature Biomedical Engineering
- Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
- (2015) Huan Meng et al. ACS Nano
- Nanoparticle biointerfacing by platelet membrane cloaking
- (2015) Che-Ming J. Hu et al. NATURE
- Antiangiogenic Therapy for Cancer: An Update
- (2012) Belal Al-Husein et al. PHARMACOTHERAPY
- Use of Size and a Copolymer Design Feature To Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-Loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model
- (2011) Huan Meng et al. ACS Nano
- Bio-inspired, bioengineered and biomimetic drug delivery carriers
- (2011) Jin-Wook Yoo et al. NATURE REVIEWS DRUG DISCOVERY
- Leukemia regression by vascular disruption and antiangiogenic therapy
- (2010) G. J. Madlambayan et al. BLOOD
- Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
- (2008) Monty Liong et al. ACS Nano
- Triggers, targets and treatments for thrombosis
- (2008) Nigel Mackman NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started